Hamza Hassan, MD
Hematologic Oncology
Research Interests:
Cellular therapy High-risk Multiple Myeloma AL amyloidosis Phase I trials CAR T-cells Fraility Patient-reported outcomes
Hematologic Oncology
Research Interests:
Cellular therapy High-risk Multiple Myeloma AL amyloidosis Phase I trials CAR T-cells Fraility Patient-reported outcomes
Related Videos
Meet the Team: Hamza Hassan, MD
Hamza Hassan, MD, thinks the future is bright for patients with Myeloma and Amyloidosis. With encouraging research and treatment development opportunities, he moved from Boston to Buffalo to join the team at Roswell Park Comprehensive ...